Record issuance and steady returns are drawing broader investor interest, but stronger data, transparency, ratings and regulatory confidence remain critical for Asia to scale participation.
Premiums reached ₹3.36t across the April–March fiscal year, with stand-alone health insurers extending their growth run and Care Health crossing ₹100bn after a 20.9% annual increase.
The IAIS's multi-year assessment of 16 jurisdictions finds resolution tools underdeveloped and liquidity stress-testing requirements uneven, even as macroprudential supervision matures.
Robotaxis are giving commercial shape to APAC’s broader AV market, but insurers remain constrained by limited data, fragmented regulation, and unresolved liability questions.
